<?xml version="1.0" encoding="UTF-8"?>
<p>There are limited data to examine the effect of pandemics in outpatient cancer settings. Chen et al. examined a prospective case series of 79 patients with non‚Äêsmall cell lung cancer (NSCLC) enrolled in chemotherapy trials in a Taiwanese hospital during the SARS epidemic. While five patients were under investigation, none were confirmed to have SARS. Results of a questionnaire showed that nearly two thirds of patients were afraid of entering a hospital for fear of acquiring SARS, and three patients ceased all further chemotherapy due to this concern. Chemotherapy delays occurred in 2.7% of administrations 
 <xref rid="onco13306-bib-0030" ref-type="ref">30</xref>.
</p>
